A new RNA-based therapy aims to address one of cardiology’s most persistent challenges: the heart’s inability to regenerate after injury.

Baseline NT-proBNP levels in Black and White patients with wild-type ATTR-CM reflect disease severity rather than inherent ...

BACKGROUND: The underlying cause of deaths attributed to acute stimulant (methamphetamine or cocaine) toxicity is poorly ...

A 65-year-old man with hypertension, type 2 diabetes, a remote myocardial infarct, and chronic kidney disease (CKD) presents for routine follow-up with his family physician. Two years prior, the ...

The relationship between cardiovascular dysfunction and renal impairment is widely recognized as the cardiorenal interaction, ...

Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for Merck’s WINREVAIR in Adults With CpcPH-HFpEF ...

CM? Drs Kevin Alexander and Ronald Witteles make the case for rethinking how we manage arrhythmias in this disease.

Positive Phase 3 results of SCOUT-HCM trial highlight potential of Camzyos to be the first cardiac myosin inhibitor for the treatment of adolescents with symptomatic obstructive hypertrophic ...

Why didn’t you recommend one of the at-home kits for the person with Lynch syndrome who had a bad reaction during her ...

I was diagnosed with a large fatty tumor on my left thigh. It’s very ugly. What can I do to get rid of it? — V.O.P.

Clinically, this makes sense, because systems of care (revascularization pathways, imaging, rhythm management, device therapy, and follow-up structures) have improved, often in ways that do not simply ...

The relationship between cardiovascular dysfunction and renal impairment is widely recognized as the cardiorenal interaction, ...